Riskpilot← Back to searchSign inGet full accessWiklund Medical AB
ABActiveOrg 5591343826Sofieholmsgatan 8General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2024
SEK 185K
-2% vs 2023
EBITDA margin
90.4%
-2% vs 2023
Equity ratio
85.0%
Financial strength
Net profit 2024
SEK 132K
-2% vs 2023
| Revenue | SEK 185K | -2% |
| EBITDA | SEK 167K | -2% |
| Net profit | SEK 132K | -2% |
| Total assets | SEK 266K | -18% |
| Equity | SEK 226K | -17% |
| Employees | 0 | — |
Legal name
Wiklund Medical AB
Org number
5591343826
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 november 2017
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva rådgivning, utbildning och konsultverksamhet rörande sjukvård och friskvård samt därmed förenlig verksamhet. Bolaget ska också äga och förvalta fast och lös egendom samt bedriva därmed förenlig verksamhet
Address
Sofieholmsgatan 8
Email
simonwiklund@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 245 | 315 | 273 | 190 | 185 |
| Staff expenses | — | — | −0 | −0 | −0 |
| EBITDA | 233 | 304 | 243 | 170 | 167 |
| Depreciation & amort. | −0 | −0 | — | — | −2 |
| EBIT | 233 | 304 | 243 | 170 | 165 |
| Net financials | — | — | — | 1 | 1 |
| Profit before tax | 233 | 305 | 243 | 171 | 167 |
| Tax | −50 | −63 | −50 | −35 | −34 |
| Net profit | 183 | 242 | 193 | 136 | 132 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 490 | 671 | 793 | 325 | 266 |
| Equity | 263 | 305 | 318 | 273 | 226 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 226 | 366 | 475 | 51 | 40 |
| Total debt | 226 | 366 | 475 | 51 | 40 |
EBITDA margin
90.4%
This company
15.8%
Market median
+472% vs market
20202024
Equity ratio
85.0%
This company
38.2%
Market median
+123% vs market
20202024
Return on equity
58.7%
This company
18.4%
Market median
+219% vs market
20202024
Net profit margin
71.6%
This company
8.1%
Market median
+784% vs market
20202024
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20202024
Debt / equity
0.18×
This company
0.62×
Market median
+71% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Wiklund Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karl Simon Wiklund | Board of Directors | 0 companies |
| Maria Wiklund | Deputy Board Member | 0 companies |